Something remarkable, and controversial, is unfolding in American medicine. The Food and Drug Administration says it is fast-tracking leucovorin, a long-established drug, for potential use in treating cerebral folate deficiency, a condition…
Continue Reading
News Source: www.statnews.com

Leave a Reply